«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:

期数:

2015年03期

页码:

275-276

栏目:

论著

出版日期:

2015-06-16

文章信息/Info

Title:

Effect of preoperative high-dose rosuvastatin on myocardial injury among patients with unstable angina pectoris after percutaneous coronary intervention (PCI)

作者:

李现立; 郑晓晖; 胡丰朝

河南省安阳地区医院，河南 安阳 455000

Author(s):

LIXian-li; ZHENG Xiao-hui; HU Feng-chao

Hospital of AnyangDistrict,Anyang,Henan455000,China Correspondingauthor:LIXian-li,E-mail:lixianli1008@163.com

关键词:

心绞痛; 瑞舒伐他汀; 经皮冠状动脉介入治疗; 心肌酶谱

Keywords:

Angina pectoris;  Rosuvastatin;  Percutaneous coronary intervention (PCI);  Myocardial enzymo-gram

分类号:

R541.4

DOI:

-

摘要:

目的 评价术前负荷剂量瑞舒伐他汀对不稳定性心绞痛经皮冠状动脉介入治疗（PCI）术后心肌损伤 的影响。方法 将89例不稳定性心绞痛患者随机分为治疗组45例和对照组44例，对照组PCI术前予常规 改善心肌缺血、抗凝、抗栓治疗，治疗组在PCI术前12 h口服瑞舒伐他汀20 mg，两组术后均给予瑞舒伐 他汀10 mg，每晚一次口服。观察两组PCI术前后高敏C反应蛋白(hs-CRP)、心肌肌钙蛋白I（cTnI）和 肌酸激酶同工酶（CK-MB）的变化及术后30 d内主要心血管事件发生例数。结果 PCI术后两组血清 h

Abstract:

Objective To observe the effect of preoperative high-dose rosuvastatin on myocardial injury among patients with unstable angina pectoris after percutaneous coronary intervention (PCI). Methods 89 patients with unstable angina pectoris were randomly divide

参考文献/References:

[1] Jemal A, Bray F,Melissa M, et al. Global cancer statistics [J].CA CancerJ Clin,2011,61(2):69-90.
[2] Chen W, Zheng R, Zhang S,et al. Report of cancer incidence and mortality in China,2010[J].Ann Transl Med, 2014,2 (7):61.
[3] Moelans CB, Milne AN, Morsink FH,et al. Low frequency of HER2amplification and overexpression in early onset gastric cancer[J].CellOncol(Dordr),2011,34(2):89-95.
[4] Kim KM, Bilous M, Chu KM,et al. Human epidermal growth factor receptor 2testing in gastric cancer: recommendations of an Asia-Pacific task force[J]. Asia Pac J Clin Oncol, 2014, 10(4):297-307.
[5] 胃癌HER2检测指南(2011版)[J].中华病理学杂志,2011,40 (8):553-557.
[6] Bang YJ, Van Cutsem E, Feyereislova A,et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment ofHER2-positive advanced gastric or gastro-oe? sophagealjunction cancer (ToGA):a phase3, open-label, ran? domised controlled trial[J]. Lancet, 2010,376(9742):687-697.
[7] Wang WJ, Lei YY, Mei JH,et al. Recent Progress in HER2 Associated Breast Cancer[J].Asian Pac J Cancer Prev,2015, 16(7):2591-2600.
[8] Sandoo A, Kitas GD, Carmichael AR. Breast cancer therapy and cardiovascular risk: focus on trastuzumab [J].Vasc Health Risk Manag,2015,11:223-228.
[9] Cappellesso R, Fassan M, Hanspeter E,et al. HER2status in gastroesophageal cancer: a tissue microarray study of1040cas? es[J].Hum Pathol,2015,46(5):665-672.
[10]Gowryshankar A, Nagaraja V, Eslick GD. HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis[J]. J GastrointestOncol,2014,5(1):25-35.
[11]Han J, Meng QY, Liu X,et al. Lack of effects of HER-2/neu on prognosis in colorectal cancer: a meta-analysis[J]. Asian Pac J CancerPrev,2014,15:5551-55556.
[12]Hirashima N, Takahashi W, Yoshii S,et al. Protein overex? pression and gene amplification of c-erbB-2in pulmonary car? cinomas: a comparative immunohistochemical and fluorescence in situ hybridization study[J].Mod Pathol, 2001,14(6):556-562.
[13]Wang Y, Wang D, Ren M. Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta- analysis [J]. TumourBiol ,2014,35:33-38.
[14]Huang D, Lu N, Fan Q, et al. HER2status in gastric and gas? troesophageal junction cancer assessed by local and central lab? oratories: Chinese results of the HER- EAGLE study[J]. PLoS One,2013Nov14,8(11):e80290.

备注/Memo

备注/Memo:

作者简介：李现立，大学本科，主治医师，主要从事心血管内科工作 通信作者：李现立，E-mail: lixianli1008@163.com

常用功能

更新日期/Last Update: 2015-06-15